Literature DB >> 11489247

Complementary and alternative medicine in prostate cancer.

J S Jacobson1, A P Chetty.   

Abstract

Prostate cancer patients, like other cancer patients as well as the general population, are increasingly exploring the use of complementary and alternative medicine (CAM). This paper describes the use of CAM in this patient population and the evidence regarding some CAM treatments in the setting of prostate cancer. Some herbal agents and micronutrients have demonstrated biologic activity that may benefit patients with prostate cancer. The clinical effects of these and others and the potential interactions among CAM treatments and with conventional treatment remain an appropriate target for further investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489247     DOI: 10.1007/s11912-001-0032-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  35 in total

1.  A study of the effect of energy healing on in vitro tumor cell proliferation.

Authors:  S Shah; A T Ogden; C M Pettker; A Raffo; S Itescu; M C Oz
Journal:  J Altern Complement Med       Date:  1999-08       Impact factor: 2.579

2.  Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.

Authors:  A de la Taille; R Buttyan; O Hayek; E Bagiella; A Shabsigh; M Burchardt; T Burchardt; D K Chopin; A E Katz
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

3.  Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.

Authors:  R K Nam; N Fleshner; E Rakovitch; L Klotz; J Trachtenberg; R Choo; G Morton; C Danjoux
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

Review 4.  Prevention of prostate cancer.

Authors:  C C Schulman; A R Zlotta; L Denis; F H Schröder; W A Sakr
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

5.  Survey of UsToo Members and Other Prostate Cancer Patients to Evaluate the Efficacy and Safety of PC-SPES.

Authors: 
Journal:  Mol Urol       Date:  1999

6.  UsToo PC-SPES surveys: review of studies and update of previous survey results.

Authors:  H Porterfield
Journal:  Mol Urol       Date:  2000

7.  Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study.

Authors:  M Hammar; J Frisk; O Grimås; M Höök; A C Spetz; Y Wyon
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

8.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

9.  Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer.

Authors:  W K Oh; D J George; K Hackmann; J Manola; P W Kantoff
Journal:  Urology       Date:  2001-01       Impact factor: 2.649

10.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

View more
  3 in total

Review 1.  Complementary and alternative medicines in prostate cancer: from bench to bedside?

Authors:  Samuel J Klempner; Glenn Bubley
Journal:  Oncologist       Date:  2012-05-22

2.  Supportive Infusions in Integrative Breast and Gynecological Oncology - Report on Patients' Satisfaction and Self-reported Effects and Side Effects.

Authors:  Carolin C Hack; Sophia Antoniadis; Matthias W Beckmann; Anna Lisa Brandl; Peter A Fasching; Janina Hackl; Hanna Langemann; Stock Katja; Natalie Weber; Anna-Katharin Theuser
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-11-26       Impact factor: 2.915

3.  Phytotherapy and other alternative forms of care for the patient with prostatitis.

Authors:  Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.